Arif Tanju Özçeli̇kAy

Arif Tanju Özçeli̇kAy

Auto-generated profile, based on publicly available information

Arif Tanju Özçeli̇kAy

Faculty of Pharmacy, Department of Pharmacology, Ankara University, Ankara, Turkey

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2021 in Chemistry and Physics of Lipids
Verified
Journal Article
Closed access
GAGULIN AMASYA
GULIN AMASYA
AEAhmet Doğan Ergin
Ahmet Doğan Ergin
OCOzge Erkan Cakirci
Ozge Erkan Cakirci
AOArif Tanju Ozçelikay
Arif Tanju Ozçelikay
ZBZerrin Sezgin Bayindir
Zerrin Sezgin Bayindir
NYNilufer Yuksel
Nilufer Yuksel

1 January 2014 in General Physiology and Biophysics
Verified
Journal Article
Open access
GMGizem Kayki Mutlu
Gizem Kayki Mutlu
EIebru arioglu inan
ebru arioglu inan
IGIsil OZAKCA GUNDUZ
Isil OZAKCA GUNDUZ
AOArif T. Ozcelikay
Arif T. Ozcelikay
VAVecdi M. Altan
Vecdi M. Altan
β3-Adrenoceptor-mediated responses in diabetic rat heart

27 June 2022 in Turkish Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
APAysel Pehli̇vAnli
Aysel Pehli̇vAnli
ASAysu Selçuk
Aysu Selçuk
ŞEŞahin Eyüpoğlu
Şahin Eyüpoğlu
ŞEŞehsuvar Ertürk
Şehsuvar Ertürk
AÖArif Tanju Özçeli̇kAy
Arif Tanju Özçeli̇kAy
This study aimed to identify the prevalence of potentially inappropriate medication use (PIMU) in adults above the age of 65 with chronic kidney disease (CKD) according to the American Geriatric Society Beers Criteria (Beers), Screening Tool of Older People’s Potentially Inappropriate Prescriptions Criteria (STOPP) and medication appropriateness index (MAI) 30 criteria and to compare them to justify their use in this specific patient group. This was a retrospective and descriptive study conducted between October 1st, 2019 and March 18th, 2020 at Ibni Sina Hospital, Nephrology Department, Faculty of Medicine, Ankara University. Among 269 patients discharged from the hospital during the study period, 100 of them were eligible for the study. The mean age was 73.3 ± 6.9 years and 51.9% of them were male. The prevalence of 35 PIMU was 91%, 42%, and 70% according to the Beers, STOPP, and MAI criteria, respectively. There was a statistically significant difference in terms of prevalence among 3 criteria (p<0.001). Beer detected more PIMU (11.3% vs. 6.4%) and had higher sensitivity among older adults with CKD (0.97 vs. 0.56) compared to the STOPP criteria. Most patients had at least one drug-drug interaction (DDIs) in their discharge prescription (93%) and DDI was one of the main contributors of PIMU. Proton pump inhibitors were the most common medication associated with PIMU in all 3 criteria. The prevalence of PIMU was high among older adults with CKD at discharge according to these criteria. To improve the prescriptions after hospital discharge, it is considered appropriate to use Beers criteria under guidance of a clinical pharmacist.

28 April 2022 in Journal of Anesthesiology and Reanimation Specialists’ Society
Verified
Journal Article
Open access
APAysel Pehlivanlı
Aysel Pehlivanlı
ÇÖÇiğdem Özgün
Çiğdem Özgün
ÇEÇağatay Fikret Erad
Çağatay Fikret Erad
AÖArif Tanju Özçelikay
Arif Tanju Özçelikay
MÜMustafa Necmettin Ünal
Mustafa Necmettin Ünal

31 December 2023 in Eurasian Journal of Health Technology Assessment
Verified
Journal Article
Open access
PDF file
ABAsım Emre BİÇER
Asım Emre BİÇER
AÖArif Tanju Özçeli̇kAy
Arif Tanju Özçeli̇kAy
Tedarik zinciri, tüketicilerin ihtiyaçlarını karşılamak üzere her türlü mal, hizmet ve bilgi akışının, ham maddenin temin ve tedariğinden ürünün tüketildiği son noktaya kadar olan tüm lojistik süreçlerinin planlanması ve yönetimi olarak tanımlamaktadır. Sağlık sektörünün yapı taşı olan ilaç doğrudan bireyin sağlığı ile ilgili olup ertelenemez olması nedeniyle istenilen kalitede, ihtiyaç duyulduğu anda teslimi çok önemli olan stratejik bir üründür. Nakliye, sevkiyat, sınırlı raf ömrü, özel saklama koşulları ve yüksek stok riskleri gibi faktörler ilaç tedarik zincirini önemli kılmakta ve ilaçlar için farklı bir tedarik zinciri yapısı gerektirmektedir. Bu çalışmada 2020 yılından itibaren Devlet Malzeme Ofisi (DMO) aracılığıyla uygulanmaya başlanan ilaç tedariğinin güçlü ve zayıf yönleri ortaya konulmaya çalışılmıştır. Merkezi tedariğin kamu ihalesi açısından faydaları düşünüldüğünde, hastanelerde ilaç tedarik zincirinin DMO aracılığıyla gerçekleştirilmesinin olumlu katkılar sağlayabileceğini söylemek mümkündür. Diğer taraftan hastanelerde ilaç tedarik sürecinde DMO sisteminin geliştirilmesi gereken birçok yönü olduğu görülmektedir. Yapılan veri tabanı taramalarında DMO aracılı ilaç tedariğini inceleyen bir araştırmaya rastlanılamamıştır. Bu kapsamda çalışmanın, literatürde eksikliği hissedilen bir alana ilgiyi artıracağı ve konu üzerinde yeni ve kapsamlı araştırmalara yol gösterici olacağı düşünülmektedir.

18 April 2024 in BMC Pharmacology and Toxicology
Verified
Journal Article
Open access
PDF file
APAysel Pehlivanli
Aysel Pehlivanli
SESayeste Akkan Eren
Sayeste Akkan Eren
SSSule Sengul
Sule Sengul
BBBILGEN BASGUT
BILGEN BASGUT
SESehsuvar Erturk
Sehsuvar Erturk
AOA. Tanju Ozcelikay
A. Tanju Ozcelikay
Background: Dialysis patients are at high risk for drug-related problems (DRPs), which have significant consequences for their morbidity, mortality, and quality of life. Improved clinical outcomes can be achieved by preventing, identifying, and resolving these problems. Methods: This is a retrospective observational study. In this study, the PAIR instrument (Pharmacotherapy Assessment in Chronic Renal Disease) was validated for use in Turkish. Validation consisted of three stages: translation back-translation with expert panel evaluation, reliability analysis using the test-retest method, and conceptual validity with both Pharmaceutical Care Network Europe (PCNE) and PAIR used to determine DRPs prevalence. Results: In total, 104 patients (mean ± SD age, 54.1 ± 15.8 years; 53.8% male) were included in the study. An expert panel evaluated the items in the criterion based on their intelligibility, service of purpose, differentiation, and cultural suitability during the translation stage. Content validity index (CVI) score was found to be 0.95. The reliability analysis was performed by applying the test-retest method and calculating correlation coefficient on 30 randomly selected patients one month later. Correlation coefficient (p) was found to be 0.8. To evaluate conceptual validity, 104 patients’ pharmacotherapy plans were assessed using both the PAIR and PCNE criteria. The prevalence of DRPs according to PAIR criteria (100.0%) and PCNE (73.1%) were statistically significantly different (p < 0.001). Conclusions: As a result, PAIR criteria can identify clinically relevant DRPs in patients with CKD and is a new, validated tool to be used in Turkey, but may not be adequate for patients receiving dialysis. Therefore, it needs to be reviewed and updated for dialysis patients.